Alec Stranahan
Stock Analyst at B of A Securities
(0.81)
# 1791
Out of 5,270 analysts
29
Total ratings
37.50%
Success rate
10.21%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Candel Therapeutics | Initiates Coverage On: Buy | 15 | 8.12 | 84.73% | 1 | Feb 7, 2025 | |
Day One Biopharmaceu... | Maintains: Buy | 28 25 | 8.53 | 193.08% | 4 | Jan 7, 2025 | |
Caribou Biosciences | Maintains: Buy | 13 11 | 1.09 | 909.17% | 1 | Jan 7, 2025 | |
Erasca | Upgrades: Buy | 5 5 | 1.3 | 284.62% | 2 | Jan 7, 2025 | |
Perspective Therapeu... | Downgrades: Neutral | 24 6 | 2.54 | 136.22% | 2 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 48 55 | 38.55 | 42.67% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 18 | 8.09 | 122.5% | 3 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 118 140 | 172.49 | -18.84% | 3 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 42 | 14.83 | 183.21% | 1 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 12 | 5.26 | 128.14% | 4 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 5 6 | 35.44 | -83.07% | 2 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 60 5 | 1.48 | 237.84% | 1 | Dec 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | 53.57 | -16% | 1 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 58 | n/a | n/a | 1 | May 20, 2022 |